Yoo C - Search Results

1

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study.

Yoo C, Kim KP, Jeong JH, Kim I, Kang MJ, Cheon J, Kang BW, Ryu H, Lee JS, Kim KW, Abou-Alfa GK, Ryoo BY. Yoo C, et al. Lancet Oncol. 2021 Nov;22(11):1560-1572. doi: 10.1016/S1470-2045(21)00486-1. Epub 2021 Oct 14. Lancet Oncol. 2021. PMID: 34656226 Clinical Trial.

2

Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinib.

Yoo C, Ryu MH, Kang BW, Yoon SK, Ryoo BY, Chang HM, Lee JL, Beck MY, Kim TW, Kang YK. Yoo C, et al. J Clin Oncol. 2010 Mar 20;28(9):1554-9. doi: 10.1200/JCO.2009.26.5785. Epub 2010 Feb 22. J Clin Oncol. 2010. PMID: 20177019

3

The efficacy and safety of sunitinib in korean patients with advanced renal cell carcinoma: high incidence of toxicity leads to frequent dose reduction.

Yoo C, Kim JE, Lee JL, Ahn JH, Lee DH, Lee JS, Na S, Kim CS, Hong JH, Hong B, Song C, Ahn H. Yoo C, et al. Jpn J Clin Oncol. 2010 Oct;40(10):980-5. doi: 10.1093/jjco/hyq073. Epub 2010 May 10. Jpn J Clin Oncol. 2010. PMID: 20457723 Clinical Trial.

4

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer.

Kang YK, Ryu MH, Yoo C, Chang HM, Yook JH, Oh ST, Kim BS, Kim TW. Kang YK, et al. Among authors: yoo c. Cancer Chemother Pharmacol. 2011 Jun;67(6):1435-43. doi: 10.1007/s00280-010-1444-4. Epub 2010 Sep 2. Cancer Chemother Pharmacol. 2011. PMID: 20811894 Clinical Trial.

5

Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailability.

Kim KP, Ryu MH, Yoo C, Ryoo BY, Choi DR, Chang HM, Lee JL, Beck MY, Kim TW, Kang YK. Kim KP, et al. Among authors: yoo c. Cancer Chemother Pharmacol. 2011 Aug;68(2):285-91. doi: 10.1007/s00280-010-1479-6. Epub 2010 Oct 19. Cancer Chemother Pharmacol. 2011. PMID: 20957481

6

Changes in imatinib plasma trough level during long-term treatment of patients with advanced gastrointestinal stromal tumors: correlation between changes in covariates and imatinib exposure.

Yoo C, Ryu MH, Ryoo BY, Beck MY, Chang HM, Lee JL, Kim TW, Kang YK. Yoo C, et al. Invest New Drugs. 2012 Aug;30(4):1703-8. doi: 10.1007/s10637-011-9633-5. Epub 2011 Jan 14. Invest New Drugs. 2012. PMID: 21234641 Clinical Trial.

7

Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800 mg/day in patients with advanced gastrointestinal stromal tumors.

Yoo C, Ryu MH, Ryoo BY, Beck MY, Kang YK. Yoo C, et al. Invest New Drugs. 2013 Oct;31(5):1367-74. doi: 10.1007/s10637-013-9961-8. Epub 2013 Apr 17. Invest New Drugs. 2013. PMID: 23591629

8

Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer.

Yoo C, Ryu MH, Na YS, Ryoo BY, Lee CW, Maeng J, Kim SY, Koo DH, Park I, Kang YK. Yoo C, et al. Invest New Drugs. 2014 Apr;32(2):271-8. doi: 10.1007/s10637-013-9983-2. Epub 2013 May 28. Invest New Drugs. 2014. PMID: 23712440 Clinical Trial.

9

Imatinib plasma monitoring-guided dose modification for managing imatinib-related toxicities in gastrointestinal stromal tumor patients.

Yoon S, Ryu MH, Yoo C, Beck MY, Ryoo BY, Kang YK. Yoon S, et al. Among authors: yoo c. J Korean Med Sci. 2013 Aug;28(8):1248-52. doi: 10.3346/jkms.2013.28.8.1248. Epub 2013 Jul 31. J Korean Med Sci. 2013. PMID: 23960456 Free PMC article.

10

Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial.

Kang YK, Ryu MH, Yoo C, Ryoo BY, Kim HJ, Lee JJ, Nam BH, Ramaiya N, Jagannathan J, Demetri GD. Kang YK, et al. Among authors: yoo c. Lancet Oncol. 2013 Nov;14(12):1175-82. doi: 10.1016/S1470-2045(13)70453-4. Epub 2013 Oct 18. Lancet Oncol. 2013. PMID: 24140183 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,626 results

Search Page